AbbVie's head of global head of immunology discovery research says the ability to profile patients at the molecular level has the potential to dramatically change treatment for people living with chronic conditions. …
New testing means patients no longer 'defined by their symptoms'
February 26, 2019 Latest NewsPharmaDispatch Executive
Latest Video
New Stories
-
Another term for PBAC chair
March 26, 2019 - - Latest News -
Is this 'Factor F' or just another announcement?
March 26, 2019 - - Latest News -
Nominations open for research awards
March 26, 2019 - -
Biogen and Eisai scrap development of aducanumab
March 25, 2019 - - Latest News -
GSK locals join global colleagues in ‘Trek For Kids’
March 25, 2019 - - Latest News -
Greg Hunt seeks advice on pre-PBAC funding
March 25, 2019 - - Latest News -
Article cites unnamed 'experts' in PBS influence claims
March 25, 2019 - - Latest News